O
CNMD icon

OppenheimerFunds’s CONMED CNMD Stock Holding History

OppenheimerFunds’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$491K Sell
5,902
-896
-13% -$65.1K ﹤0.01% 1376
2018
Q4 		$436K Buy
6,798
+122
+2% +$8.35K ﹤0.01% 1418
2018
Q3 		$529K Sell
6,676
-248
-4% -$19.2K ﹤0.01% 1421
2018
Q2 		$507K Sell
6,924
-822
-11% -$55.9K ﹤0.01% 1420
2018
Q1 		$491K Sell
7,746
-2,765
-26% -$165K ﹤0.01% 1405
2017
Q4 		$536K Sell
10,511
-228
-2% -$11.9K ﹤0.01% 1477
2017
Q3 		$563K Sell
10,739
-871
-8% -$43.7K ﹤0.01% 1466
2017
Q2 		$592K Sell
11,610
-2,239
-16% -$111K ﹤0.01% 1427
2017
Q1 		$615K Buy
13,849
+3,343
+32% +$144K ﹤0.01% 1406
2016
Q4 		$464K Buy
10,506
+1,747
+20% +$74.2K ﹤0.01% 1420
2016
Q3 		$351K Buy
8,759
+602
+7% +$25.6K ﹤0.01% 1433
2016
Q2 		$389K Buy
8,157
+760
+10% +$32.2K ﹤0.01% 1352
2016
Q1 		$310K Sell
7,397
-1,473
-17% -$57.8K ﹤0.01% 1436
2015
Q4 		$391K Buy
+8,870
New +$385K ﹤0.01% 1390

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's CNMD Position: Q1 2019 in Review

OppenheimerFunds reduced its CONMED (CNMD) stake by 13% in Q1 2019, selling an estimated $65.1K and leaving 5,902 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1376.

OppenheimerFunds first reported a position in CNMD in Q4 2015 and has held it in 14 quarters since. The position peaked at $615K in Q1 2017. 226 funds tracked by Wall St. Rank hold CNMD as of Q1 2019.

  • OppenheimerFunds held 5,902 shares of CONMED worth $491K as of Q1 2019.
  • OppenheimerFunds sold 896 CONMED shares in Q1 2019, an estimated $65.1K.
  • CONMED made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1376 holding.
  • OppenheimerFunds first reported a position in CONMED in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's CONMED position peaked at $615K in Q1 2017.
  • 226 funds tracked by Wall St. Rank held CONMED as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.